Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Axon Enterprise | AXON | Nov 22, 2024 | 636.95 | +0.90 |
Baker Hughes A | BKR | Nov 22, 2024 | 44.25 | -1.40 |
Ball | BALL | Nov 22, 2024 | 61.86 | +1.69 |
Bank Of America | BAC | Nov 22, 2024 | 47.00 | +1.16 |
Bank Of New York Mellon | BK | Nov 22, 2024 | 80.14 | +1.60 |
Baxter International | BAX | Nov 22, 2024 | 33.21 | +0.67 |
Becton, Dickinson And Co | BDX | Nov 22, 2024 | 224.00 | -0.64 |
Berkshire Hathaway B | BRK-B | Nov 22, 2024 | 476.57 | +0.96 |
Best Buy | BBY | Nov 22, 2024 | 89.54 | +3.50 |
Bio-Techne | TECH | Nov 22, 2024 | 71.28 | +0.32 |
Biogen | BIIB | Nov 22, 2024 | 157.90 | -0.07 |
BlackRock | BLK | Nov 22, 2024 | 1 036.46 | +0.82 |
Blackstone | BX | Nov 22, 2024 | 199.05 | +2.60 |
Boeing | BA | Nov 22, 2024 | 149.29 | +4.10 |
Booking | BKNG | Nov 22, 2024 | 5 177.15 | -0.65 |
BorgWarner | BWA | Nov 22, 2024 | 34.12 | +1.07 |
Boston Properties | BXP | Nov 22, 2024 | 80.66 | -0.14 |
Boston Scientific | BSX | Nov 22, 2024 | 90.00 | -1.64 |
Bristol-Myers Squibb | BMY | Nov 22, 2024 | 58.87 | +1.10 |
Broadcom | AVGO | Nov 22, 2024 | 164.23 | +0.18 |
Broadridge Financial Solutions | BR | Nov 22, 2024 | 230.24 | +1.22 |
Brown & Brown | BRO | Nov 22, 2024 | 112.05 | +1.17 |
Brown Forman B | BF-B | Nov 22, 2024 | 41.37 | +1.67 |
Builders Firstsource | BLDR | Nov 22, 2024 | 178.52 | +1.48 |
Bunge | BG | Nov 22, 2024 | 87.65 | -0.81 |
C.H. Robinson Worldwide | CHRW | Nov 22, 2024 | 107.61 | -0.86 |
Cadence Design Systems | CDNS | Nov 22, 2024 | 311.87 | +1.75 |
Caesars Entertainment | CZR | Nov 22, 2024 | 37.60 | +0.11 |
Camden Property Trust | CPT | Nov 22, 2024 | 122.90 | +0.75 |
Campbell Soup | CPB | Nov 22, 2024 | 45.29 | +1.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.